1
|
Hussain SP and Harris CC: Inflammation and
cancer: An ancient link with novel potentials. Int J Cancer.
121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Landskron G, De la Fuente M, Thuwajit P,
Thuwajit C and Hermoso MA: Chronic inflammation and cytokines in
the tumor microenvironment. J Immunol Res. 2014(149185)2014.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Schetter AJ, Heegaard NH and Harris CC:
Inflammation and cancer: Interweaving microRNA, free radical,
cytokine and p53 pathways. Carcinogenesis. 31:37–49. 2010.
View Article : Google Scholar :
|
5
|
Schauer IG, Zhang J, Xing Z, Guo X,
Mercado-Uribe I, Sood AK, Huang P and Liu J: Interleukin-1β
promotes ovarian tumorigenesis through a p53/NF-κB-mediated
inflammatory response in stromal fibroblasts. Neoplasia.
15:409–420. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Lin JT, Wang JY, Chen MK, Chen HC, Chang
TH, Su BW and Chang PJ: Colon cancer mesenchymal stem cells
modulate the tumorigenicity of colon cancer through interleukin 6.
Exp Cell Res. 319:2216–2229. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Anton K, Banerjee D and Glod J:
Macrophage-associated mesenchymal stem cells assume an activated,
migratory, pro-Inflammatory phenotype with increased IL-6 and
CXCL10 secretion. PLoS One. 7:e350362012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Huang F, Wang M, Yang T, Cai J, Zhang Q,
Sun Z, Wu X, Zhang X, Zhu W, Qian H and Xu W: Gastric
cancer-derived MSC-secreted PDGF-DD promotes gastric cancer
progression. J Cancer Res Clin Oncol. 140:1835–1848. 2014.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Deshmane SL, Kremlev S, Amini S and Sawaya
BE: Monocyte chemoattractant protein-1 (MCP-1): An overview. J
Interferon Cytokine Res. 29:313–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhang J, Patel L and Pienta KJ: CC
chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis
and metastasis. Cytokine Growth Factor Rev. 21:41–48. 2010.
View Article : Google Scholar :
|
11
|
Li X, Xu Q, Wu Y, Li J, Tang D, Han L and
Fan Q: A CCL2/ROS autoregulation loop is critical for
cancer-associated fibroblasts-enhanced tumor growth of oral
squamous cell carcinoma. Carcinogenesis. 35:1362–1370. 2014.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Chen C, Duckworth CA, Fu B, Pritchard DM,
Rhodes JM and Yu LG: Circulating galectins -2, -4 and -8 in cancer
patients make important contributions to the increased circulation
of several cytokines and chemokines that promote angiogenesis and
metastasis. Br J Cancer. 110:741–752. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Rokavec M, Wu W and Luo JL: IL6-mediated
suppression of miR-200c directs constitutive activation of
inflammatory signaling circuit driving transformation and
tumorigenesis. Mol Cell. 45:777–789. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wu J, Liu X and Wang Y: Predictive value
of preoperative serum CCL2, CCL18 and VEGF for the patients with
gastric cancer. BMC Clin Pathol. 13(15)2013. View Article : Google Scholar
|
15
|
Tao LL, Shi SJ, Chen LB and Huang GC:
Expression of Monocyte chemotactic protein-1/CCL2 in gastric cancer
and its relationship with tumor hypoxia. World J Gastroenterol.
20:4421–4427. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006.PubMed/NCBI
|
17
|
Aggarwal BB and Gehlot P: Inflammation and
cancer: How friendly is the relationship for cancer patients? Curr
Opin Pharmacol. 9:351–369. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Abe M, Yamashita S, Kuramoto T, Hirayama
Y, Tsukamoto T, Ohta T, Tatematsu M, Ohki M, Takato T, Sugimura T
and Ushijima T: Global expression analysis of
N-methyl-N′-nitro-N-nitrosoguanidine-induced rat stomach carcinomas
using oligonucleotide microarrays. Carcinogenesis. 24:861–867.
2003. View Article : Google Scholar : PubMed/NCBI
|
19
|
Raphael KR, Sabu M, Kumar KH and Kuttan R:
Inhibition of N-Methyl-N′-nitro-N-nitrosoguanidine (MNNG) induced
gastric carcinogenesis by Phyllanthus amarus extract. Asian Pac J
Cancer Prev. 7:299–302. 2006.PubMed/NCBI
|
20
|
Li JX, Wang ZB, Zhu LQ, Niu FL and Cui W:
Effects of Radix notoginseng extracts drug-containing serum on
expressions of bcl-2, Bax and p21WAF1 proteins in MNNG transformed
GES-1 cells. Zhong Xi Yi Jie He Xue Bao. 6:817–820. 2008.PubMed/NCBI
|
21
|
Kundu JK and Surh YJ: Inflammation:
Gearing the journey to cancer. Mutat Res. 659:15–30. 2008.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Xu Y, Zhao Y, Xu W, Luo F, Wang B, Li Y,
Pang Y and Liu Q: Involvement of HIF-2α-mediated inflammation in
arsenite-induced transformation of human bronchial epithelial
cells. Toxicol Appl Pharmacol. 272:542–550. 2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Luo F, Xu Y, Ling M, Zhao Y, Xu W, Liang
X, Jiang R, Wang B, Bian Q and Liu Q: Arsenite evokes IL-6
secretion, autocrine regulation of STAT3 signaling and miR-21
expression, processes involved in the EMT and malignant
transformation of human bronchial epithelial cells. Toxicol Appl
Pharmacol. 273:27–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Fujimoto H, Sangai T, Ishii G, Ikehara A,
Nagashima T, Miyazaki M and Ochiai A: Stromal MCP-1 in mammary
tumors induces tumor-associated macrophage infiltration and
contributes to tumor progression. Int J Cancer. 125:1276–1284.
2009. View Article : Google Scholar : PubMed/NCBI
|
25
|
Lu Y, Cai Z, Galson DL, Xiao G, Liu Y,
George DE, Melhem MF, Yao Z and Zhang J: Monocyte chemotactic
protein-1 (MCP-1) acts as a paracrine and autocrine factor for
prostate cancer growth and invasion. Prostate. 66:1311–1318. 2006.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Li M, Knight DA, A Snyder L, Smyth MJ and
Stewart TJ: A role for CCL2 in both tumor progression and
immunosurveillance. Oncoimmunology. 2:e254742013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Fang WB, Jokar I, Zou A, Lambert D,
Dendukuri P and Cheng N: CCL2/CCR2 chemokine signaling coordinates
survival and motility of breast cancer cells through Smad3 protein-
and p42/44 mitogen-activated protein kinase (MAPK)-dependent
mechanisms. J Biol Chem. 287:36593–36608. 2012. View Article : Google Scholar : PubMed/NCBI
|
28
|
Ma Y, Adjemian S, Galluzzi L, Zitvogel L
and Kroemer G: Chemokines and chemokine receptors required for
optimal responses to anticancer chemotherapy. Oncoimmunology.
3:e276632014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Wolf MJ, Hoos A, Bauer J, Boettcher S,
Knust M, Weber A, Simonavicius N, Schneider C, Lang M, Stürzl M, et
al: Endothelial CCR2 signaling Induced by colon carcinoma cells
enables extravasation via the JAK2-Stat5 and p38MAPK Pathway.
Cancer Cell. 22:91–105. 2012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Gao J, Wang A, Zhang M, Li H, Wang K, Han
Y, Wang Z, Shi C and Wang W: RNAi targeting of CCR2 gene expression
induces apoptosis and inhibits the proliferation, migration and
invasion of PC-3M cells. Oncol Res. 21:73–82. 2013. View Article : Google Scholar
|
31
|
Lu Y, Chen Q, Corey E, Xie W, Fan J,
Mizokami A and Zhang J: Activation of MCP-1/CCR2 axis promotes
prostate cancer growth in bone. Clin Exp Metastasis. 26:161–169.
2009. View Article : Google Scholar
|
32
|
Furukawa S, Soeda S, Kiko Y, Suzuki O,
Hashimoto Y, Watanabe T, Nishiyama H, Tasaki K, Hojo H, Abe M and
Fujimori K: MCP-1 promotes invasion and adhesion of human ovarian
cancer cells. Anticancer Res. 33:4785–4790. 2013.PubMed/NCBI
|
33
|
Voulgari A and Pintzas A:
Epithelial-mesenchymal transition in cancer metastasis: Mechanisms,
markers and strategies to overcome drug resistance in the clinic.
Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI
|
34
|
Zhang H, Liu L, Wang Y, Zhao G, Xie R, Liu
C, Xiao X, Wu K, Nie Y, Zhang H and Fan D: KLF8 involves in
TGF-beta-induced EMT and promotes invasion and migration in gastric
cancer cells. J Cancer Res Clin Oncol. 139:1033–1042. 2013.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Peng Z, Wang CX, Fang EH, Wang GB and Tong
Q: Role of epithelial-mesenchymal transition in gastric cancer
initiation and progression. World J Gastroenterol. 20:5403–5410.
2014. View Article : Google Scholar : PubMed/NCBI
|